Paradigm Peptides owner sentenced to 70 months in federal prison
Matthew J. Kawa pleaded guilty to introducing unapproved new drugs into interstate commerce with intent to defraud. DOJ says the company sold to 54,000 customers and that some products labeled as SARMs were testosterone.
Published October 3, 2026 · Twenty Residues editorial
What the record establishes
- Sentencing was announced by the U.S. Attorney's Office, Northern District of Indiana, on July 30, 2026. Kawa received 70 months' prison and one year supervised release; his sister Jennifer L. Stechkober received 16 months and one year.
- Kawa pleaded guilty to introducing unapproved new drugs into interstate commerce with intent to defraud and mislead, and to illegally importing merchandise. Both defendants were ordered to pay $78,317.52 in restitution; a $5 million money judgment was entered against Kawa.
- DOJ states the business claimed FDA registration, U.S. manufacturing, and in-house testing, while in fact importing from China and India and not testing. Lab analysis found many products sold as SARMs were testosterone.
- DOJ states Kawa received FDA warning letters in 2020 and 2022 and continued selling; from 2019 to 2024 the business sold to more than 54,000 customers in 50 states and over 80 countries.
What it does not establish
- The charges and the reported harms center on mislabeled SARMs and false claims about origin and testing. The press release does not identify any peptide product as adulterated or mislabeled.
- This is one vendor. The record does not characterize the rest of the market, in either direction.
- DOJ's statement that customers were 'poisoned' is the U.S. Attorney's characterization of the harm reports, not a toxicology finding stated in the release.
What would change this
The sentencing memorandum or plea agreement, which would list the specific products and lab results, or an appeal.
The open question
The decisive evidence in this case was that products were not what the label said. Every argument about peptides, for or against, assumes the vial contains the peptide. How often is that assumption actually checked, and by whom?
We don't answer this one. Take it to wherever you argue about peptides, and send us the strongest case from either side.
Propose a question by emailor on the public record
Sources
- [1]
- [2]CBS News — Judge sentences peptide vendor to nearly 6 years in prison
secondaryNews report